Pharmacologic interleukin (IL)-1 and IL-6 inhibitors. IL-1β and IL-1α... | Download Scientific Diagram
Frontiers | Interleukin-1 in the Response of Follicular Helper and Follicular Regulatory T Cells
Interleukin Inhibitor Cheatsheet
Interleukin-1-Blocker: Evidenz spricht nicht für deutliche Wirkung bei COVID-19 | Cochrane Deutschland
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease | Circulation Research
Figure 1 from The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review | Semantic Scholar
The IL-1 family of cytokines and receptors in rheumatic diseases | Nature Reviews Rheumatology
Immunology - Interleukin 1 (IL1) physiology and IL1 antagonist pharmacology - YouTube
Frontiers | The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis
Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis | Annals of the Rheumatic Diseases
Blocking IL-1 to prevent respiratory failure in COVID-19 | Critical Care | Full Text
Interleukin 1 Receptor, Type II - an overview | ScienceDirect Topics
Frontiers | IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect
interaction of iL-1 and iL-1 receptor antagonist with the iL-1 receptor... | Download Scientific Diagram
Interleukin-1 function and role in rheumatic disease | Nature Reviews Rheumatology
IL-1 pathways in inflammation and human diseases | Nature Reviews Rheumatology
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study - The Lancet Rheumatology
Interleukin-1 Inhibition at Treatment for Rheumatoid Arthritis on Johns Hopkins Arthritis
Interleukin-1 Inhibition at Treatment for Rheumatoid Arthritis on Johns Hopkins Arthritis
The role of interleukin-1 in general pathology | Inflammation and Regeneration | Full Text
Frontiers | Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease | Circulation Research
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond. - Abstract - Europe PMC
